Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU politicos press for April regulation on clinical data disclosure

This article was originally published in Scrip

Executive Summary

The continuing currency and economic crisis in Europe, spiced this week by the panic in Cyprus’s banking system, has not deflected European politicians from the much more urgent business of trying to loosen pharma’s hold on clinical data. In the European Parliament, MEPs backed calls for trial data to be published when a new drug has been approved for marketing. While most of the vocal members favored data publication, opinions differed as to how much data should be released, at what point and in what manner.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts